| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | Feb 5, 2025 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.65% | ✗ | $3.1K |
| Feb 4, 2025 | Feb 4, 2025 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.65% | ✗ | $3K |
| Dec 20, 2024 | Jan 29, 2025 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.67% | ✗ | $2.8K |
| Jan 28, 2025 | Jan 29, 2025 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 67.5 | +1,500 | 0.98% | ✗ | $4.1K |
| Jan 13, 2025 | Jan 24, 2025 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 77.5 | +3,000 | 2.01% | ✗ | $7.7K |
| Oct 28, 2024 | Oct 30, 2024 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 60.0 | +500 | 0.34% | ✗ | $1.1K |
| Aug 13, 2024 | Aug 15, 2024 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.68% | ✗ | $950 |
| Jun 28, 2024 | Jul 1, 2024 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.69% | ✗ | $1.8K |
| Jun 18, 2024 | Jun 21, 2024 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 77.5 | +1,619 | 1.12% | ✗ | $1.1K |
| Jun 10, 2024 | Jun 12, 2024 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 77.5 | +3,000 | 2.13% | ✗ | $1.9K |
| Sep 16, 2022 | Sep 20, 2022 | Nexalin Technology, Inc. | Chief Medical Officer | Buy | 78.8 | +2,500 | 1.80% | ✗ | $10.4K |